baber/WOPTO huggingface dataset:
Patent BR-PI0912207-B1 (BR)
Title: comutador de transformador
Inventor: KURT LAWRENCE LINDSEY
IPC: H01H37/58
Filed: 2009-05-05
Abstract: MÚLTIPLOS CONJUNTOS DE CÂMARA DE ARCO PARA UM INTERRUPTOR DE FALHA E COMUTADOR DE INTERRUPÇÃO DE CARGA. Um interruptor de falha e comutador de interrupção de carga inclui um conjunto de disparo configurado para automaticamente abrir um circuito de transformador eletricamente acoplado a contatos estacionários do comutador, quando da ocorrência de uma condição de falha. A condição de falha faz com que um elemento de metal de Curie eletricamente acoplado a pelo menos um dos contatos estacionários libere um engate magnético. A liberação faz com que o rotor de disparo do conjunto de disparo rode um conjunto de rotor. Esta rotação faz com que as extremidades de um contato móvel do conjunto de rotor eletricamente se desencaixem dos contatos estacionários, desse modo se abrindo o circuito. O comutador também inclui um punho para a abertura manual e o fechamento do circuito elétrico em condições de falha e não de falha. Uma atuação do punho acoplado ao conjunto de rotor através de um rotor carregado por mola faz com que as extremidades de contato móvel seletivamente se encaixem ou desencaixem dos contatos estacionários .
Patent BR-PI0912843-B1 (BR)
Title: Método paratamponar cartucho de anestésico e dispositivo para transferir volume de solução tampão para cartucho de anestésico
Inventor: MATTHEW J STEPOVICH
IPC: A61M37/00
Filed: 2009-05-11
Abstract: MÉTODO PARA TAMPONAR QUALQUER CARTUCHO DE ANESTÉSICO, DISPOSITIVO PARA TRANSFERIR UM VOLUME DE SOLUÇÃO TAMPÃO PARA DENTRO DE UM CARTUCHO DE ANESTÉSICO, MÉTODO PARA ARMAZENAR UMA SOLUÇÃO TAMPÃO DE BICARBONATO, E, CONJUNTO DE CARTUCHO DE ARMAZENAGEM DE TAMPÃO DE BICARBONATO. Um dispositivo para a liberação de solução tampão em um cartucho de tampão compreende um conjunto de agulha e um impulsor. Os septos de um cartucho de tampão e um cartucho de anestésico são avançados em uma agulha de transferência, e o impulsor avança um êmbolo no cartucho de tampão para dispensar o tampão através da agulha de transferência para dentro do cartucho de anestésico. Um agulha de descarga separada permite que o excesso de anestésico seja descarregado. Um elemento de compressão é geralmente fornecido para manter uma força contra o êmbolo no cartucho de tampão para pressurizar e estabilizar o conteúdo durante a esterilização e/ou armazenagem.
Patent BR-PI0920949-B1 (BR)
Title: Turbina a gás para transformar energia térmica em trabalho mecânico
Inventor: OLE BJORN KLEVEN
IPC: F02C7/08
Filed: 2009-11-24
Abstract: TURBINA A GÁS PARA TRANSFORMAR ENERGIA TÉRMICA EM TRABALHO MECÂNICO. A inveção se refere a uma turbina a gás (10) para transformar energia térmica, por exemplo, a partir de carvão, biomassa ou similar, to trabalho mecânico, compreendendo uma unidade de compressor (11), uma unidade de turbina (13), uma câmara de combustão (15) e a trocador de calor (14) com sistema de tubo associado. A turbina a gás (10) é configurada de uma tal maneira que o calor seja fornecido para o fluxo de ar entre a unidade de compressor (11) e a unidade de turbina (13) por meio de gás residual quente a partir da câmara de combustão (15) e é levado para dentro de uma câmara de compressão (12) arranjada entre a unidade de compressor (11) e a unidade de turbina (13).
Patent BR-PI1002708-B1 (BR)
Title: Dispositivo dosador
Inventor: SILVIO LEITZKE
IPC: A47F1/03
Filed: 2010-07-14
Abstract: dispositivo dosador. a presente patente de invenção refere-se a um dispositivo dosador (1) dotado de comportas, que compreende um prolongamento tubular (20) inferior, cuja abertura inferior é fechada por um par de comportas primárias movíveis (21); e compreende ainda um elemento tubular (3) ao redor do prolongamento (20), cuja abertura inferior é posicionada abaixo da abertura do prolongamento (2), e é fechada por um par de comportas secundárias movíveis (31) que, ao serem abertas libertam o produto retido entre as comportas primárias (21) e secundárias (31) para empacotamento; e ainda, a altura do elemento tubular (3) pode ser alterada de forma a permitir o controle de quantidade de produto a empacotar.
Patent BR-PI1009228-B1 (BR)
Title: Cache configurável e método para configuração da mesma
Inventor: AJAY ANANT INGLE
IPC: G06F12/0895
Filed: 2010-03-03
Abstract: ARMAZENADOR CONFIGURÁVEL E MÉTODO PARA CONFIGURAÇÃO DO MESMO. Em uma modalidade particular, um armazenador é descrito e inclui um conjunto de estados de indicador que inclui uma área de indicador endereçável por um índice de conjunto. O conjunto de estados de indicador também inclui uma área de estado endereçável por um endereço de estado, em que o índice de conjunto e o endereço de estado inclui pelo menos um bit comum.
Patent BR-PI1015990-B1 (BR)
Title: Compósitos à base de resíduos de couro com polivinil butiral (pvb)
Inventor: ALESSANDRA LUCAS MARINELLI
IPC: C14B7/04
Filed: 2010-04-07
Abstract: compósitos à base de resíduos de couro com polivinil butiral (pvb) são descritas compósitos à base de resíduos de couro e poli(vinhl butirai) (pvb) compreendendo, em proporçao em massa, entre 10 e 70% de resíduos de couro, e o balanço de poli(vinil butiral), além dos aditivos usuais empregados na técnica. os compósitos são obtidos por moagem das fibras de couro, secagem das fibras e da matriz poliméríca, mistura a seco dos componentes e extrusão. a obtenção dos compósitos da invenção evita que resíduos de couro e de pvb sejam descartados em aterros sanitários.
Patent EA-000465-B1 (EA)
Title: Process for producing caprolactam
Inventor: FUCHS EBERHARD
IPC: C07D223/12
Filed: 1996-05-07
Abstract: 1. A process for preparing caprolactam by reacting 6-aminocapronitrile with water at a raised temperature, wherein the cyclization is conducted in liquid phase in the presence of a tetrahydroazepine derivative of the formula   in the presence of a heterogeneous catalyst. 2. A process as claimed in Claim 1, wherein the heterogeneous catalyst contains no constituents that are soluble under the conditions of the reaction. 3. A process as claimed in Claim 1 or 2, wherein the reaction is carried out in a fixed bed reactor. 4. A process as claimed in any of Claims 1 to 3, wherein the reaction is carried out in the presence of a heterogeneous catalyst based on titanium dioxide, zirconium dioxide, cerium oxide or aluminum oxide. 5. A process as claimed in any of Claims 1 to 4, wherein the catalyst used comprises titanium dioxide having an anatase content within the range from 5 to 100% by weight and a rutile content within the range from 0 to 95% by weight, based on the total amount of titanium dioxide. 6. A process as claimed in any of Claims 1 to 5, wherein the starting mixture has a UV number (sum of all absorbencies of a 10% by weight solution in ethanol at wavelengths from 280 to 400 nm, based on a pathlength of 5 cm) within the range from 5 to 40,000.
Patent EA-013944-B1 (EA)
Title: A method for preparing a non-naturally occurring antigen-presenting cell line and use said cell line for the treatment of tumors
Inventor: DEGRAW JULI
IPC: A61K38/21
Filed: 2002-02-19
Abstract: T cell responses are often diminished in humans with a compromised immune system. We have developed a method to isolate, stimulate and expand naive cytotoxic T lymphocyte precursors (CTLp) to antigen-specific effectors, capable of lysing tumor cells in vivo. This ex vivo protocol produces fully functional effectors. Artificial antigen presenting cells (AAPCs; Drosophila melanogaster ) transfected with human HLA class I and defined accessory molecules, are used to stimulate CD8+ T cells from both normal donors and cancer patients. The class I molecules expressed to a high density on the surface of the Drosophila cells are empty, allowing for efficient loading of multiple peptides that results in the generation of polyclonal responses recognizing tumor cells endogenously expressing the specific peptides. The responses generated are robust, antigen-specific and reproducible if the peptide epitope is a defined immunogen. This artificial antigen expression system can be adapted to treat most cancers in a significant majority of the population.
Patent EA-007221-B1 (EA)
Title: PYRIDO-PYRIDO-PYRROLO[3,2-g]-PYRROLO[3,4-e]]INDOLE AND PYRIDO-PYRROLO[2,3-a]PYRROLO[3,4-c]-CARBAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES
Inventor: PRUDHOMME MICHELLE
IPC: A61P35/00
Filed: 2002-06-28
Abstract: Compounds of formula (I)wherein:Wand Wrepresent, with the carbon atoms to which they are bound, a phenyl group or a pyridinyl group, and at least one of the groups Wor Wrepresent a pyridinyl group;Rand Reach represent a group of formula U-V as defined in the description;Ris as defined in the description;X and Y represent together with the carbon atom that they include, a carbonyl or thiocarbonyl group;X and Yrepresent together with the carbon atom that they include, a carbonyl or thiocarbonyl group;Rand Rare as defined in the description;Q, Qrepresent a hydrogen atom, oQand Q, together with the carbon atoms that they include, form an aromatic link.Medicaments.
Patent EA-006792-B1 (EA)
Title: Ultrasonic method for measuring a flow rate of liquid and/or gaseous media and device for carrying out said method
Inventor: DEREVYAGIN ALEXANDER MIKHAILOVICH
IPC: G01F1/66
Filed: 2005-03-04
Abstract: The invention relates to measuring engineering. The aim of said invention is to increase the accuracy of measurement of liquid and/or gaseous medium flow rate. For this purpose, the inventive method consists in emitting ultrasonic oscillations upstream and downstream of a measurable medium, in receiving oscillation crossing said medium, convening said oscillations into electrical signals, in analysing the electric signals in order to determine the difference between the upstream and downstream oscillation transit time for calculating the medium flow rate using at least two reversible eleclroacoustic transducers each of which has a directive diagram with an apex angle equal to or greater than 60° on different planes of section and is disposed on a pipeline measuring section in such a way that the directive diagram axis is substantially perpendicular to the longitudinal axis of the pipeline.
Patent EA-010763-B1 (EA)
Title: A method and system of depth control for maintaining a coil tubing conveyed tool in a desired location in a cased wellbore during wellbore operations
Inventor: MILLER CHARLES
IPC: E21B47/04
Filed: 2006-06-19
Abstract: A depth control system for maintaining a tubing conveyed tool in a desired location in a cased wellbore during wellbore operations performed with the tool includes a bottom hole assembly carried by a coiled tubing, the bottom hole assembly including a tool and an anchoring device actuated to engage the casing and a sensor operationally connected to a surface unit for displaying depth readings to determine the predetermined position of the casing to perform a wellbore operation. A method for maintaining a tool at a desired depth in a cased wellbore while performing wellbore operations with the tool comprising a bottom hole assembly having a tool, an anchor device and a sensor, conveying a tool and an anchoring device on a coiled tubing to a desired depth in cased wellbore, the sensor operationally connected to a surface unit for displaying depth readings and conveying them to the surface unit, operating the tool to perform a wellbore operation and actuating the anchoring device to engage the casing and maintain the tool at the desired depth.
Patent EA-011811-B1 (EA)
Title: Use of methylene amide derivatives in cardiovascular disorders
Inventor: HOOFT VAN HUIJSDUIJNEN ROB
IPC: A61P9/10
Filed: 2005-02-25
Abstract: The present invention is related to the use of substituted methylene amide derivatives of Formula (I) for the treatment and/or prevention of cardiovascular disorders such as coronary obstruction and heart failure. In particular, the present invention is related to the use of substituted methylene amide derivatives of Formula (I) in particular for the treatment and/or prevention of endothelial dysfunction in heart failure.
Patent EA-016441-B1 (EA)
Title: Collecting line for tubular reformers
Inventor: MEISSNER OLIVER
IPC: B01J8/00
Filed: 2007-10-30
Abstract: Collecting line for removing hot process gases conducted in process gas tubes from tubular reformers, wherein the collecting line has on the inside at least one insulation layer made of fire-resistant concrete or fire-resistant brick, and on the outside a wall made of a metallic outer tube, comprises a plurality of stubs via which the process gas tubes of the tubular furnace can be connected to the collecting line, wherein in the region of the stubs, the process gas tubes are at least in part conducted in guide tubes, and each gas outlet connected to the respective process gas tube projects into the collecting line, by means of which the process gas is introduced into the collecting line in correct functioning, and at least one gas outlet is constructed as a pipe bend.
Patent EA-019118-B1 (EA)
Title: Method for silk fibroin gelation, controlling gelation time, a method of encapsulating at least one agent in silk fibroin (embodiments)
Inventor: WANG XIAOQIN
IPC: A61K35/24
Filed: 2008-05-29
Abstract: This invention relates to a process of silk fibroin gelation, comprising the silk fibroin treatment, including the ultrasonication treatment, in the time period ranging from about 5 to about 60 seconds to initiate gelation, wherein substantial silk fibroin gelation forms less than 24 hours after the ultrasonication treatment, wherein the silk fibroin is in the form of an aqueous solution having a pH about 7.5 or higher. The invention also relates to a method of controlling gelation time of silk fibroin by contacting a silk fibroin solution with an ultrasonication treatment for a sufficient period of time to initiate gelation. Methods are also proposed of encapsulating at least one agent in silk fibroin, comprising contacting a silk fibroin solution with an ultrasonication treatment for a period of time to initiate gelation, wherein the silk fibroin is in the form of an aqueous solution having a pH about 7.5 or higher. The silk-fibroin encapsulated biological material produced by said method is suitable for a biodelivery device.
Patent EA-017114-B1 (EA)
Title: N-(pyrazole-3-yl)benzamide derivatives as glucokinase activators
Inventor: BURGDORF LARS THORE
IPC: A61K31/4155
Filed: 2008-09-09
Abstract: Disclosed are novel compounds selected from the following groups: No."A1" - 3-benzyloxy-5-isopropoxy-N-(1-pyridine-2-ylmethyl-1H-pyrazol-3-yl)benzamide; No."A2" - 3-benzyloxy-5-isopropoxy-N-(5-methyl-1-pyridine-2-ylmethyl-1H-pyrazole-3-yl)benzamide; No."A3" - 3-benzyloxy-N-(1-benzyl-1H-pyrazol-3-yl)-5-isopropoxybenzamide; No."A4" - N-(1-benzyl-1H-pyrazole-3-yl)-3-((S)-2-methoxy-1-methylethoxy)-5-((S)-1-methyl-2-phenylethoxy)benzamide; No."A5" - 3-((S)-2-methoxy-1-methylethoxy)-5-((S)-1-methyl-2-phenylethoxy)-N-(1-pyridine-2-ylmethyl-1H-pyrazole-3-yl)benzamide; No."A6" - 3-isopropoxy-N-(1-pyridine-2-ylmethyl-1H-pyrazole-3-yl)-5-(2-thiophene-3-ylethoxy)benzamide; No."A7" - 3-((S)-2-methoxy-1-methylethoxy)-5-((S)-1-methyl-2-phenylethoxy)-N-(1-pyridine-3-ylmethyl-1H-pyrazole-3-yl)benzamide; No."A8" - 3-((S)-2-methoxy-1-methylethoxy)-5-((S)-1-methyl-2-phenylethoxy)-N-(1-pyridine-4-ylmethyl-1H-pyrazole-3-yl)benzamide; No."A9" - N-(1-benzyl-1H-pyrazol-3-yl)-3-isopropoxy-5-(2-thiophen-3-ylethoxy)benzamide; No."A10" - 3-(4-methanesulfonylphenoxy)-5-((S)-2-methoxy-1-methylethoxy)-N-(1-pyridin-3-ylmethyl-1H-pyrazol-3-yl)benzamide, and pharmaceutically usable salts and stereoisomers thereof, including mixtures thereof in all ratios, which are activators of glucokinase and can be used for the prevention and/or treatment of diabetes Type 1 and 2, obesity, neuropathy and/or nephropathy.
Patent EA-018901-B1 (EA)
Title: N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin dreceptors
Inventor: HUTCHINSON JOHN HOWARD
IPC: C07C235/34
Filed: 2009-01-29
Abstract: Described herein are compounds that are antagonists of PGDreceptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein that are antagonists of PGDreceptors. Also described herein are methods of using such antagonists of PGDreceptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD-dependent or PGD-mediated conditions or diseases.
Patent EA-021579-B1 (EA)
Title: Valve assembly for removal of liquid medium and method for controlling a valve assembly
Inventor: MATZKE ARNO
IPC: E03D5/00
Filed: 2011-10-25
Abstract: The invention relates to a valve assembly for the removal of a liquid medium, comprising an inlet opening, an outlet opening, a controllable flow preventing valve arranged in the installed position between the inlet and the outlet openings, and a control device which is designed to release or block the flow preventing valve for the flow of the liquid medium, characterized by a backflow preventing valve arranged in the installed position between the inlet and the outlet and in the direction of gravity substantially above the flow preventing valve, the backflow preventing valve having a backflow output disposed in the installed position in the direction of gravity substantially downwardly, and further characterized in that the control device is adapted to block the flow preventing valve in such a way that a residual portion of the medium to be removed in the direction of gravity substantially above the flow preventing valve forms a barrier layer, whose surface is arranged in the direction of gravity substantially above the backflow output of the backflow preventing valve.
Patent EA-020221-B1 (EA)
Title: Intaglio printing ink comprising dendrimers
Inventor: TRACHSEL NICOLAS
IPC: C09D11/101
Filed: 2009-06-23
Abstract: An ink for the engraved copperplate intaglio printing inks is disclosed, which comprises high-molecular weight dendritic polymer as a binder component. Inks comprising such polymer can be formulated so as to contain a significantly reduced amount of organic solvent (volatile organic components, VOC) whilst still being in the appropriate viscosity range required by the intaglio printing process. The printed and cured intaglio ink of the present invention has improved chemical and mechanical resistance properties.
Patent EA-022996-B1 (EA)
Title: Sampling system
Inventor: WISSER JOERG
IPC: G01N1/20
Filed: 2010-04-19
Abstract: A sampling system (10) which has a first connecting piece (14) for connecting to a pipe traversed by fluid and a third connecting piece (20), and having a cock (24) which has a basic body (26) with a longitudinal axis (1), about which the cock (24) can be pivoted between a first end position and a second end position, and with a sampling recess (28), wherein in the first end position, the sampling recess (28) can be connected via the first connecting piece (14) to the pipe traversed by media, and in the second end position, the sampling recess (28) can be connected to the third connecting piece (20), wherein the third connecting piece (20) is connected to a first end (40a) of an extraction needle (40) which can be pierced with a second end (40b) through a membrane (48) of a sampling volume (44), wherein in the second end position, the sampling recess (28); is connected via the third connecting piece (20) to a first end (42a) of a ventilation needle (42).
Patent EA-027884-B1 (EA)
Title: Dental surgical laser with feedback mechanisms
Inventor: BELIKOV ANDREI V
IPC: A61N5/067
Filed: 2010-12-31
Abstract: A surgical device based on the concept of controlling the laser power during laser surgery based on optical and other signals from the tip and the tissue is described. A laser surgical system generally comprises several basic components, such as a laser, a delivery system, a tip and a control system. A tip may be considered as a particular case of a thermo-optical tip (TOT). TOT is an optical and mechanical element which could be used to modify or treat soft and hard tissues, including cutting, coagulation, vaporization, carbonization, and ablation of tissues.
Patent EA-021869-B1 (EA)
Title: Method for purifying a fused pyrrolocarbazole derivative
Inventor: ALLWEIN SHAWN P
IPC: C07D487/14
Filed: 2011-05-17
Abstract: The present invention relates a method for purifying a fused pyrrolocarbazole compound known as 11-isobutyl-2-methyl-8-(2-pyrimidinylamino)-2,5,6,11,12,13-hexahydro-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one using an acid complex thereof. The present invention also relates to a crystalline form of the acid complex.
Patent EA-039080-B1 (EA)
Title: Intranasal testosterone bio-adhesive gel formulations and use thereof for treating male hypogonadism
Inventor: KREPPNER WAYNE
IPC: A61K47/44
Filed: 2012-05-15
Abstract: The invention relates to pernasal testosterone bio-adhesive gel formulations for intranasal administration and testosterone replacement treatment methods for using the pernasal testosterone bio-adhesive gel formulations for providing sustained intranasal delivery of testosterone to testosterone deficient males to treat, for example, male subjects diagnosed with hypogonadism.
Patent EA-030015-B1 (EA)
Title: NOVEL POLYMORPHIC CRYSTAL FORMS OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO}-1-(R)-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE HEMINAPADISYLATE AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR
Inventor: AMAT MESTRES GEMMA
IPC: C07D215/26
Filed: 2013-03-15
Abstract: The application describes novel polymorphic crystal forms of a 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one heminapadisylate. The application also describes pharmaceutical compositions comprising said polymorphic crystal forms, methods of using them to treat respiratory diseases associated with β2 adrenergic receptor activity and a process for preparing such polymorphic crystal forms.
Patent EA-030517-B1 (EA)
Title: Method of manipulating equipment associated with a gelled fluid having a transient gel microstructure (embodiments) and corresponding computer
Inventor: JAMISON DALE
IPC: E21B43/00
Filed: 2013-02-12
Abstract: Equipment associated with a gelled fluid may be manipulated based on a stress response of the gelled fluid as determined by a gel microstructure destruction model comprising an equivalent work integral function. Further, systems and devices may be configured to manipulated equipment associated with a gelled fluid based on a stress response of the gelled fluid as determined by a gel microstructure destruction model comprising an equivalent work integral function.
Patent EA-025166-B1 (EA)
Title: Pyridine derivatives
Inventor: ANSELM LILLI
IPC: A61K31/444
Filed: 2013-08-19
Abstract: The invention relates to a compound of formula (I)wherein A, Aand Rto Rare defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
Patent EA-033636-B1 (EA)
Title: Biodegradable additive concentrate improving the lubricity of aqueous sludges, use thereof and aqueous sludge for drilling
Inventor: DELORME GERALDINE
IPC: C09K8/12
Filed: 2013-12-23
Abstract: A biodegradable additive concentrate having a pour point in accordance with the ASTM D97 standard lower than -5°C, improving the lubricity of aqueous sludges, comprising at least one compound chosen from the group consisting of mono- and diesters of diglycerol; acids and ester derivatives of monocarboxylic fatty acids comprising between 16 and 22 carbon atoms per chain; acids and ester derivatives of resin acids; polyol monoesters comprising more than 4 hydroxylated groups and carboxylic fatty acids comprising between 6 and 12 saturated and unsaturated carbon atoms with an unsaturation number of at least 1; mono- and polyalkoxylated esters of saturated and unsaturated dicarboxylic acids comprising between 6 and 12 carbon atoms. The use of this concentrate in an aqueous sludge and the aqueous sludge comprising said concentrate that can be used for drilling.